Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: H&R GmbH & Co. KGaA

Market Cap 18Cr 21Cr 16Cr 15Cr 29Cr 1.95TCr 29Cr 193.19Cr 75Cr 951.05Cr 77Cr 76Cr 3.29TCr P/E Ratio 2026 *
30.3x
P/E Ratio 2027 * 22.4x
Enterprise Value 33Cr 39Cr 31Cr 29Cr 54Cr 3.67TCr 55Cr 363.05Cr 141.55Cr 1.79TCr 144.98Cr 141.9Cr 6.19TCr EV / Sales 2026 *
0.26x
EV / Sales 2027 * 0.25x
Free-Float
22.35%
Yield 2026 *
1.05%
Yield 2027 * 1.05%
15/05 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
31/03 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
28/01 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
15/11 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
14/11 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/25/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/25/15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/25/16 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/25/14 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/25/17 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/25/09 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
27/25/27 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
27/25/27 H&R GmbH & Co. KGaA Announces Postponement of the Publication of the Consolidated Financial Statements and the Annual Report 2024 CI
1 day+2.58%
1 week-1.04%
Current month+0.63%
1 month+0.42%
3 months+10.93%
6 months+0.42%
Current year+11.19%
1 week 4.55
Extreme 4.55
4.8
1 month 4.46
Extreme 4.46
4.86
Current year 3.91
Extreme 3.91
4.88
1 year 3.91
Extreme 3.91
5.04
3 years 3.23
Extreme 3.23
5.48
5 years 3.23
Extreme 3.23
10.35
10 years 3.23
Extreme 3.23
19.58
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
+2.58%-1.04%-4.02%-9.32% 21Cr
+1.99%+0.94%+1.27%+28.19% 12TCr
+0.18%-1.16%-0.54%-37.66% 4.42TCr
+6.73%-1.09%+31.72%-20.03% 3.32TCr
+9.91%+1.91%+262.24%+34.47% 2.67TCr
+0.61%-1.41%+39.07%+79.91% 2.48TCr
+1.75%+0.12%+7.45%-28.83% 2.08TCr
+1.74%+8.39%+126.48%+12.58% 2.06TCr
+3.51%-2.11%+446.07%+660.09% 1.92TCr
+4.55%+4.46%+96.42%+238.46% 1.84TCr
Average +3.35%+2.88%+100.62%+95.79% 3.32TCr
Weighted average by Cap. +2.96%+2.26%+67.07%+62.63%

Financials

2026 *2027 *
Net sales 129.35Cr 149.76Cr 119.2Cr 111.57Cr 209.1Cr 14TCr 212.33Cr 1.41TCr 548.75Cr 6.93TCr 562.06Cr 550.09Cr 24TCr 133.02Cr 154.02Cr 122.58Cr 114.74Cr 215.04Cr 15TCr 218.37Cr 1.45TCr 564.34Cr 7.13TCr 578.03Cr 565.72Cr 25TCr
Net income 58.49L 67.72L 53.9L 50.45L 94.55L 64Cr 96.01L 6.36Cr 2.48Cr 31Cr 2.54Cr 2.49Cr 108.48Cr 79.95L 92.57L 73.67L 68.96L 1.29Cr 88Cr 1.31Cr 8.7Cr 3.39Cr 43Cr 3.47Cr 3.4Cr 148.28Cr
Net Debt 16Cr 18Cr 14Cr 13Cr 25Cr 1.72TCr 26Cr 169.86Cr 66Cr 836.21Cr 68Cr 66Cr 2.9TCr 16Cr 18Cr 15Cr 14Cr 26Cr 1.74TCr 26Cr 171.73Cr 67Cr 845.43Cr 69Cr 67Cr 2.93TCr
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,692
Date Price Change Volume
12/26/12 4.770 +2.58% 4,547
11/26/11 4.650 +0.43% 0
10/26/10 4.630 +0.22% 0
09/26/09 4.620 -3.55% 2,223
08/26/08 4.790 -0.62% 1,130
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
4.770EUR
Average target price
4.300EUR
Spread / Average Target
-9.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2HRA Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!